SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION OF 1-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE, 4-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE, AND 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE AS DOPAMINE RECEPTOR LIGANDS

被引：42

作者：

CHARIFSON, PS

WYRICK, SD

HOFFMAN, AJ

SIMMONS, RMA

BOWEN, JP

MCDOUGALD, DL

MAILMAN, RB

机构：

[1] UNIV N CAROLINA,SCH PHARM,DIV MED CHEM & NAT PROD,CHAPEL HILL,NC 27599

[2] UNIV N CAROLINA,SCH MED,DEPT PSYCHIAT,BIOL SCI RES CTR,CHAPEL HILL,NC 27599

[3] UNIV N CAROLINA,SCH MED,DEPT PHARMACOL,CHAPEL HILL,NC 27599

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1988年 / 31卷 / 10期

关键词：

D O I：

10.1021/jm00118a012

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

收藏

页码：1941 / 1946

页数：6

相关论文

共 35 条

[1] CHARACTERIZATION OF THE BINDING OF H-3-SCH 23390, A SELECTIVE D-1 RECEPTOR ANTAGONIST LIGAND, IN RAT STRIATUM
BILLARD, W
RUPERTO, V
CROSBY, G
IORIO, LC
BARNETT, A
[J]. LIFE SCIENCES, 1984, 35 (18) : 1885 - 1893
[2] CALNE DB, 1980, TRENDS PHARM SCI, V3, P412
[3] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[4] PHARMACOLOGICAL EFFECTS OF A SPECIFIC DOPAMINE D-1 ANTAGONIST SCH-23390 IN COMPARISON WITH NEUROLEPTICS
CHRISTENSEN, AV
ARNT, J
HYTTEL, J
LARSEN, JJ
SVENDSEN, O
[J]. LIFE SCIENCES, 1984, 34 (16) : 1529 - 1540
[5] Clarke H. T., 1933, J AM CHEM SOC, V55, P4571, DOI 10.1021/ja01338a041
[6] CLEMENTCORMIER YC, 1979, BIOCH PHARM, V23, P3123
[7] OCCURRENCE OF A NEW CLASS OF TETRAHYDROISOQUINOLINE ALKALOIDS IN L-DOPA-TREATED PARKINSONIAN PATIENTS
COSCIA, CJ
BURKE, W
JAMROZ, G
LASALA, JM
MCFARLANE, J
MITCHELL, J
OTOOLE, MM
WILSON, ML
[J]. NATURE, 1977, 269 (5629) : 617 - 619
[8] COSTENTIN J, 1983, CNS RECEPTORS MOL PH, P289
[9] DOPAMINE-RECEPTORS IN THE CENTRAL NERVOUS-SYSTEM
CREESE, I
MORROW, AL
LEFF, SE
SIBLEY, DR
HAMBLIN, MW
[J]. INTERNATIONAL REVIEW OF NEUROBIOLOGY, 1982, 23 : 255 - 301
[10] THE CLASSIFICATION OF DOPAMINE-RECEPTORS - RELATIONSHIP TO RADIOLIGAND BINDING
CREESE, I
SIBLEY, DR
HAMBLIN, MW
LEFF, SE
[J]. ANNUAL REVIEW OF NEUROSCIENCE, 1983, 6 : 43 - 71

← 1 2 3 4 →